National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Aceclofenac (Vitafen®) is indicated for the relief of pain and inflammation in osteoarthritis, rheumatoid arthritis and ankylosing spondylitis.

Rapid Review

Commenced Completed Outcome
22/07/2016

 

24/08/2016

 

Reimbursement not recommended

 

21/12/2016 24/01/2017 Following a resubmission of the rapid review a full pharmacoeconomic evaluation is recommended at the submitted price.

The HSE has approved reimbursement following confidential price negotiations  Nov 2017.